These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15598483)

  • 1. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.
    Schwartz S; Hassman D; Shelmet J; Sievers R; Weinstein R; Liang J; Lyness W
    Clin Ther; 2004 Oct; 26(10):1663-78. PubMed ID: 15598483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus.
    Ignaut DA; Fu H
    J Diabetes Sci Technol; 2012 Mar; 6(2):389-93. PubMed ID: 22538152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
    Kreugel G; Keers JC; Kerstens MN; Wolffenbuttel BH
    Diabetes Technol Ther; 2011 Jul; 13(7):737-41. PubMed ID: 21476936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between shorter straight and thinner microtapered insulin injection needles.
    Nagai Y; Ohshige T; Arai K; Kobayashi H; Sada Y; Ohmori S; Furukawa K; Kato H; Kawata T; Ohta A; Tanaka Y
    Diabetes Technol Ther; 2013 Jul; 15(7):550-5. PubMed ID: 23621793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.
    Iwanaga M; Kamoi K
    Diabetes Technol Ther; 2009 Feb; 11(2):81-6. PubMed ID: 19848573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes.
    Miwa T; Itoh R; Kobayashi T; Tanabe T; Shikuma J; Takahashi T; Odawara M
    Diabetes Technol Ther; 2012 Dec; 14(12):1084-90. PubMed ID: 23030357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pen needle preference in a population of Canadians with diabetes: results from a recent patient survey.
    Berard L; Cameron B; Woo V
    Can J Diabetes; 2015 Jun; 39(3):206-9. PubMed ID: 25732758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preference for a new prefilled insulin pen compared with the original pen.
    Garg S; Bailey T; DeLuzio T; Pollom D
    Curr Med Res Opin; 2011 Dec; 27(12):2323-33. PubMed ID: 21988614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes.
    Bergenstal RM; Strock ES; Peremislov D; Gibney MA; Parvu V; Hirsch LJ
    Mayo Clin Proc; 2015 Mar; 90(3):329-38. PubMed ID: 25662503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study.
    De Berardis G; Scardapane M; Lucisano G; Abbruzzese S; Bossi AC; Cipponeri E; D'Angelo P; Fontana L; Lancione R; Marelli G; Sciangula L; Nicolucci A
    Curr Med Res Opin; 2018 Sep; 34(9):1699-1704. PubMed ID: 29924641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
    Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.
    Hayes RP; Muchmore D; Schmitke J
    Curr Med Res Opin; 2007 Feb; 23(2):435-42. PubMed ID: 17288697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
    Cappelleri JC; Cefalu WT; Rosenstock J; Kourides IA; Gerber RA
    Clin Ther; 2002 Apr; 24(4):552-64. PubMed ID: 12017400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.